51. Organisation for Economic Co-operation and Development (OECD). (2023). Health at a glance 2023: OECD indicators. https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239.html 52. Greene, S. J., et al. (2019). Titration of medical therapy for heart failure with reduced ejection fraction. Journal of the American College of Cardiology, 73(19), 2365–2383. https://pubmed.ncbi.nlm.nih.gov/30844480/ 53. Edmonston, D., et al. (2024). Concordance with screening and treatment guidelines for chronic kidney disease in type 2 diabetes. JAMA network open, 7(6), e2418808. https://doi.org/10.1001/jamanetworkopen.2024.18808 54. Financial Services Agency. (2025, March 11). Press conference by KATO Katsunobu, Minister of Finance and Minister of State for Financial Services. https://www.fsa.go.jp/en/conference/minister/2025/20250311.html 55. Organisation for Economic Co-operation and Development (OECD) and European Observatory on Health Systems and Policies. (2023). Greece: country health profile 2023, state of health in the EU. https://www.oecd.org/en/ publications/2023/12/greece-country-health-profile-2023_0d70aae7.html 56. Ibid. 57. Italian National Institute of Statistics (ISTAT). (2024). System of health accounts (SHA). https://www.istat.it/en/statistical- themes/economy/national-accounts/ 58. FAVO (Federazione italiana delle Associazioni di Volontariato in Oncologia). (2024). 16th report on the welfare status of cancer patients. https://www.istat.it/en/statistical-themes/economy/national-accounts/ 59. Organisation for Economic Co-operation and Development (OECD). (2023). Health at a glance 2023: OECD indicators. https://www.oecd.org/en/publications/2023/11/health-at-a-glance-2023_e04f8239.html 60. Ibid. 61. Kupis, R., et al. (2024). Specialty choices among new generation of doctors – insights from a Polish survey study. Scientific Reports, 14, 27855. https://www.nature.com/articles/s41598-024-79079-7 62. Organisation for Economic Co-operation and Development (OECD) and European Observatory on Health Systems and Policies. (2023). Greece: Country health profile 2023, state of health in the EU. https://www.oecd.org/en/ publications/2023/12/greece-country-health-profile-2023_0d70aae7.html 63. Johna, S. (2024). Ärztemangel – strukturelle Probleme und mögliche Gegenmaßnahmen [in German]. https://doi.org/10.30433/GWA2024-28 64. Sachverständigenrat Zur Begutachtung Der Entwicklung Im Gesundheitswesen Und In Der Pflege. (2024). Nachhaltiger Einsatz einer knappen Ressource – Gutachten 2024 Fachkräfte im Gesundheitswesen [in German]. https://doi. org/10.4126/FRL01-006473488 65. Wangler, J., & Jansky, M. (2024). Sicherstellung der hausärztlichen Versorgung in Deutschland [in German]. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz, 67 (9), 998–1009. https://pmc.ncbi.nlm.nih.gov/ articles/PMC11349858/ 66. Ministry of Health, Labour and Welfare (MHLW). (2016). Status of placement and safety management of medical devices. https://www.mhlw.go.jp/file/05-Shingikai-10801000-Iseikyoku-Soumuka/0000130336.pdf 67. Health and Global Policy Institute (HGPI), et al. (2023). Joint statement on the implementation of comprehensive genomic profiling test. https://hgpi.org/en/research/ncd-pcm-20231215.html 68. IQVIA Institute for Human Data Science. (2024). Global trends in R&D 2024: Activity, productivity, and enablers. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2024-activity- productivity-and-enablers 69. Johns, A., et al. (2025). EU joint clinical assessment: A framework for optimising use with cost-effectiveness decision- making. Journal of Market Access & Health Policy, 13(4), 52. https://doi.org/10.3390/jmahp13040052 70. European Federation of Pharmaceutical Industries and Associations. (2025, May). EFPIA patients W.A.I.T. indicator 2024 survey. https://efpia.eu/media/oeganukm/efpia-patients-wait-indicator-2024-final-110425.pdf 71. Hofmarcher, T., Berchet, C., & Dedet, G. (2024). Access to oncology medicines in EU and OECD countries. OECD Health Working Papers No. 170. https://www.oecd.org/en/publications/access-to-oncology-medicines-in-eu-and-oecd- countries_c263c014-en.html 72. Bujar, M., & McAuslane, N. (2020). R&D briefing 81: New drug approvals in six major authorities 2011–2020: Focus on facilitated regulatory pathways and worksharing. Centre for Innovation in Regulatory Science (CIRS). https://cirsci.org/ publications/cirs-rd-briefing-81-new-drug-approvals-in-six-major-authorities-2011-2020/ 73. Universitat Oberta de Catalunya. (2022, April 22). La historia clínica electrònica en la UE: La historia clínica electronica todavía no es una realidad e la Unión Europea [in Spanish]. https://www.uoc.edu/es/news/2022/096-historia-clinica-europa 74. GKV-Spitzenverband. (2025). Digitale gesundheitsanwendungen (DiGA) [in German]. www.gkv-spitzenverband.de/ krankenversicherung/digitalisierung/kv_diga/diga.jsp 75. Cabinet Office Japan. (2023). Public opinion survey on use of information and communication equipment [in Japanese]. https://survey.gov-online.go.jp/hutai/r05/r05-it_kiki/ 76. Plataforma de Organizaciones de Pacientes. (2023). Cronicidad y estrategias de e-salud: La importancia del perfil digital [in Spanish]. https://plataformadepacientes.org/cpt_informe/cronicidad-y-estrategias-de-e-salud-la-importancia-del- perfil-digital/ Acting Early on Non-Communicable Diseases: A Framework for Health System Transformation 30

Acting Early on Non-Communicable Diseases 2026